A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MRZ-9547 in Healthy Subjects

Trial Profile

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MRZ-9547 in Healthy Subjects

Planning
Phase of Trial: Phase I

Latest Information Update: 14 Apr 2016

At a glance

  • Drugs MRZ 9547 (Primary)
  • Indications Fatigue
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 14 Apr 2016 New trial record
    • 08 Jun 2014 Study design presented at 18th International Congress of Parkinson's Disease and Movement Disorders.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top